#United States #New York #oncology #IDEAYA Biosciences #Clinical Data

IDEAYA Biosciences to Celebrate Its 10-Year Anniversary with R&D Day

IDEAYA Biosciences, Inc., a prominent player in the field of precision medicine oncology, is gearing up for an exciting milestone. On September 8, 2025, the company will mark its 10-year anniversary by hosting an in-person and virtual Research and Development (R&D) Day. This pivotal event will take place from 8:00 AM to 10:00 AM ET, based in the bustling heart of New York City.

Overview of the Event

During the R&D Day, IDEAYA will present several updates pertaining to its clinical pipeline, reflecting its commitment to the discovery and development of targeted therapeutics aimed at addressing significant unmet medical needs in cancer treatment. The session will not only unveil multiple clinical data updates across the pipeline but will also sketch a comprehensive picture of the company's future growth strategy, upcoming milestones, and scientific focus areas that are crucial for the next phase of their development as a leader in precision medicine oncology.

In a statement regarding the event, Yujiro S. Hata, the President and CEO of IDEAYA Biosciences, emphasized the significance of this anniversary. "This year marks IDEAYA's ten-year anniversary since our founding, and we look forward to providing multiple clinical data updates across our potential first-in-class pipeline, as well as sharing our strategic vision," said Hata. "We'll focus on priority areas of scientific interest and emerging aspects of our clinical pipeline that will propel our journey as a global leader in precision medicine oncology."

Agenda Highlights

The R&D Day will feature presentations from various senior leaders within IDEAYA and will also include discussions with key opinion leaders in the field. The presentations will cover detailed insights into the current state of the company’s clinical pipeline, enabling stakeholders and the scientific community to grasp the potential advancements being made.

Additionally, prospective attendees can easily register for the R&D Day by visiting the investor section of the IDEAYA website (https://ir.ideayabio.com/events). This accessibility ensures that anyone interested in the innovations of IDEAYA can engage and stay informed about the company's journey towards breakthroughs in cancer treatment.

About IDEAYA Biosciences

Founded with a mission to revolutionize cancer treatment, IDEAYA Biosciences is dedicated to the integration of small molecule drug discovery, structural biology, and bioinformatics. With extensive capabilities in the identification and validation of translational biomarkers, the company aims to develop potentially first-in-class targeted therapies tailored to specific patient populations. Their robust pipeline showcases a focus on therapeutic areas highlighting synthetic lethality and antibody-drug conjugates (ADCs), along with bispecific drugs, all with an overarching goal of enhancing clinical outcomes for cancer patients globally.

As IDEAYA approaches this landmark anniversary, the anticipation surrounding its R&D Day reflects not just a celebration of the past decade, but a significant look forward into the future of cancer therapy—a future where targeted treatments could change lives.

Conclusion

Mark your calendars for an event that promises to illuminate the path that IDEAYA Biosciences is charting in precision medicine. With groundbreaking data and an ambitious growth strategy, the R&D Day on September 8, 2025, is set to be a cornerstone event for the company as it strides into its next decade of innovation in oncology.